Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
8.15
+0.28 (3.58%)
Nov 21, 2024, 10:25 AM EST - Market open

Cryo-Cell International Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for CCEL.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for CCEL.

Recommendation Trends

Rating Aug '22
Strong Buy 0
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 0

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Initiates
$12
Strong Buy Initiates $12 +47.21% Aug 29, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
32.59M
from 31.34M
Increased by 3.97%
Revenue Next Year
32.89M
from 32.59M
Increased by 0.91%
EPS This Year
0.30
from -1.14
EPS Next Year
0.08
from 0.30
Decreased by -72.41%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Nov 30, 2019 Nov 30, 2020 Nov 30, 2021 Nov 30, 2022 Nov 30, 2023 Nov 30, 2024 Nov 30, 2025 Nov 30, 2026
Revenue
31.82M31.15M28.88M30.34M31.34M32.59M32.89M33.21M
Revenue Growth
8.89%-2.10%-7.26%5.03%3.32%3.97%0.91%0.99%
EPS
0.270.450.250.33-1.140.300.080.23
EPS Growth
-66.67%-44.44%30.95%---72.41%187.50%
Forward PE
-----27.5699.9034.75
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 33.5M 33.9M 34.2M
Avg 32.6M 32.9M 33.2M
Low 31.3M 31.6M 31.9M

Revenue Growth

Revenue Growth 202420252026
High
7.0%
3.9%
4.0%
Avg
4.0%
0.9%
1.0%
Low
-0.1%
-3.0%
-3.0%

EPS Forecast

EPS 202420252026
High 0.30 0.08 0.24
Avg 0.30 0.08 0.23
Low 0.28 0.08 0.23

EPS Growth

EPS Growth 202420252026
High -
-71.6%
196.0%
Avg -
-72.4%
187.5%
Low -
-73.5%
176.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.